Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation’s fire?

Abstract

Lymphangiogenesis is a recognized hallmark of inflammatory processes in tissues and organs as diverse as the skin, heart, bowel, and airways. In clinical and animal models wherein the signaling processes of lymphangiogenesis are manipulated, most studies demonstrate that an expanded lymphatic vasculature is necessary for the resolution of inflammation. The fundamental roles that lymphatics play in fluid clearance and immune cell trafficking from the periphery make these results seemingly obvious as a mechanism of alleviating locally inflamed environments: the lymphatics are simply providing a drain. Depending on the tissue site, lymphangiogenic mechanism, or induction timeframe, however, evidence shows that inflammation-associated lymphangiogenesis (IAL) may worsen the pathology. Recent studies have identified lymphatic endothelial cells themselves to be local regulators of immune cell activity and its consequential phenotypes – a more active role in inflammation regulation than previously thought. Indeed, results focusing on the immunocentric roles of peripheral lymphatic function have revealed that the basic drainage task of lymphatic vessels is a complex balance of locally processed and transported antigens as well as interstitial cytokine and immune cell signaling: an interplay that likely defines the function of IAL. This review will summarize the latest findings on how IAL impacts a series of disease states in various tissues in both preclinical models and clinical studies. This discussion will serve to highlight some emerging areas of lymphatic research in an attempt to answer the question relevant to an array of scientists and clinicians of whether IAL helps to fuel or extinguish inflammation. Impact statement Inflammatory progression is present in acute and chronic tissue pathologies throughout the body. Lymphatic vessels play physiological roles relevant to all medical fields as important regulators of fluid balance, immune cell trafficking, and immune identity. Lymphangiogenesis is often concurrent with inflammation and can potentially aide or worsen disease progression. How new lymphatic vessels impact inflammation and by which mechanism is an important consideration in current and future clinical therapies targeting inflammation and/or vasculogenesis. This review identifies, across a range of tissue-specific pathologies, the current understanding of inflammation-associated lymphangiogenesis in the progression or resolution of inflammation.

Serum adipokine concentrations in patients with type 2 diabetes: the relationships with distribution, hypertrophy and vascularization of subcutaneous adipose tissue

“…Заметим, что функция лимфатических коллекторов в процессе воспаления не сводится лишь к транспорту антигенов и иммунокомпетентных клеток: эндотелиоциты лимфатических капилляров способны регулировать активность и фенотип иммуноцитов. В различных условиях лимфангиогенез может как тормозить, так и усугублять течение воспалительных процессов [26].…”

Gut Lymphangiopathy: Adding Fuel to the Fire in Chronic Liver Disease

“…The growth of lymphatic vessels or lymphangiogenesis is actively involved in multiple pathological conditions, including tissue and organ inflammation [32]. In particular, lymphangiogenesis could be advantageous in decreasing inflammation related to lymphedema [24].…”

“…The lymphatic capillaries of the small intestine are fenestrated. In addition, they are surrounded by a fragmented basement membrane with anchoring filaments attached at the abluminal place[24]. Intestinal lymphatic pathophysiology in cholestatic rats could be related to inflammation, with increased Th1 and Th2 lymphocyte activation in the small bowel and in the mesenteric lymph complex of microsurgical extrahepatic cholestatic rats[26].The drainage function of lymphatic vessels is crucial for inflammation in the intestinal interstitium.…”

Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies—A review

“…The molecular and cellular mechanisms of lymphangiogenesis involved in organ graft rejection, cancer metastasis, and lymphedema are discussed in detail elsewhere. Moreover, lymphangiogenesis has an active and complex role in pathological circumstances such as inflammation, possibly including allergies and asthma . A common factor in these diverse lymphangiogenic‐related conditions is activation of the VEGF pathway, which includes ligands (VEGF‐C, VEGF‐D), receptors (VEGFR2 and VEGFR3), intracellular signaling enzymes (PI3K, mitogen‐activated protein kinases), and transcription factors (Prox‐1).…”